Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Concord Biotech Ltd is a research and development-driven biopharmaceutical company. It specializes in manufacturing Active Pharmaceutical Ingredients (APIs). The company operates in the biotechnology sector. Concord Biotech has established itself as a significant player in the industry. The company was founded in the year 2000, which makes it decades old. The headquarters of Concord Biotech Ltd is located in Ahmedabad, Gujarat. The company's main product includes APIs and finished formulations for various therapeutic areas. These products are essential for treating various medical conditions and are widely used in the industry. Read More...
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Total Revenue | 1,050.72 | 888.48 | 736.35 | 543.70 | - |
Total Expenses | 641.53 | 568.42 | 495.19 | 330.21 | - |
Profit Before Tax | 412.56 | 322.01 | 237.52 | 213.64 | - |
Profit After Tax | 308.10 | 240.09 | 174.93 | 169.11 | - |
Operating Profit after Depreciation | 411.75 | 324.56 | 246.64 | 214.19 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Fixed Assets | 575.32 | 592.98 | 572.98 | 239.60 | - |
Total Non Current Assets | 804.48 | 786.28 | 680.13 | 401.93 | - |
Total Current Assets | 896.23 | 727.70 | 632.67 | 538.79 | - |
TOTAL ASSETS | 1,700.71 | 1,513.98 | 1,312.79 | 940.73 | - |
Total Shareholder's Fund | 1,526.65 | 1,290 | 1,103.22 | 770.23 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 265.47 | 246 | 207.47 | 155.09 | - |
Net Cash used in Investing Activities | -154.61 | -157.95 | -111.79 | -113.93 | - |
Net Cash used in Financing Activities | -99.21 | -85.22 | -100.16 | -42.52 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 1,050.72 | 888.48 | 736.35 | 630.75 | 543.70 |
Total Expenses | 641.53 | 568.42 | 495.19 | 317.58 | 330.21 |
Profit Before Tax | 409.19 | 320.05 | 241.16 | 313.17 | 213.49 |
Profit After Tax | 304.73 | 238.13 | 178.57 | 235.33 | 168.96 |
Operating Profit after Depreciation | 411.75 | 324.56 | 246.64 | 313.83 | 214.19 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 575.32 | 592.98 | 572.98 | 546.22 | 239.60 |
Total Non Current Assets | 803.08 | 786.95 | 680.79 | 575.70 | 401.78 |
Total Current Assets | 896.23 | 727.70 | 632.67 | 607.15 | 538.79 |
TOTAL ASSETS | 1,699.32 | 1,514.65 | 1,313.46 | 1,182.84 | 940.58 |
Total Shareholder's Fund | 1,525.25 | 1,291.98 | 1,107.16 | 999.67 | 770.08 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 265.47 | 246 | 207.47 | 166.81 | 154.94 |
Net Cash used in Investing Activities | -154.61 | -157.95 | -111.79 | -195.20 | -113.78 |
Net Cash used in Financing Activities | -99.21 | -85.22 | -100.16 | 31.12 | -42.52 |
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 310.18 | 215.80 | 318.97 | 240.80 | 262.35 |
Total Expenses | 176.47 | 134.52 | 186.88 | 134.86 | 146.62 |
Profit Before Tax | 130.33 | 79.52 | 128.72 | 103.11 | 109.72 |
Profit After Tax | 95.74 | 59.59 | 95.02 | 77.57 | 81.02 |
Operating Profit after Depreciation | 143.74 | 92.94 | 142.90 | 117.15 | 123.86 |
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 310.18 | 215.80 | 318.97 | 240.80 | 262.35 |
Total Expenses | 173.51 | 134.52 | 184.68 | 134.86 | 143.15 |
Profit Before Tax | 133.29 | 78.17 | 130.92 | 100.09 | 113.19 |
Profit After Tax | 98.70 | 58.24 | 97.21 | 74.55 | 84.49 |
Operating Profit after Depreciation | 146.70 | 91.59 | 145.10 | 114.13 | 127.33 |
₹8.75/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Concord Biotech Ltd | ₹2,159.30 | ₹22,589.78 |
Sun Pharmaceuticals Industries Ltd | ₹1,761.80 | ₹4,22,714.84 |
Divis Laboratories Ltd | ₹5,818.40 | ₹1,54,460.24 |
Cipla Ltd | ₹1,427.30 | ₹1,15,270.75 |
Dr Reddys Laboratories Ltd | ₹1,288.45 | ₹1,07,511.36 |
Torrent Pharmaceuticals Ltd | ₹3,157.60 | ₹1,06,862.73 |
06 Nov 2024, 09:53 am
29 Aug 2024, 02:30 pm
31 Jul 2024, 02:25 pm
31 May 2024, 04:57 pm
28 May 2024, 02:30 pm
View More